The vast majority of patients with cancer in the U.S. are treated at community hospitals and practices. It is therefore paramount that precision medicine oncology technologies that are rapidly becoming the standard of care for patients with advanced cancer be available to these facilities. Not only is there a delivery issue, there is a need to encourage the widespread uptake of precision genomics by community oncology practices. This will not only facilitate potentially better patient care but also aid in recruiting patients to clinical trials. However, considerable challenges exist in implementing a precision medicine programs, including administrative, logistic, and financial barriers. This session will feature community hospital representatives that will discuss their institution's experience and challenges with implementing precision medicine programs.
Biography
Dr. Pellini is Managing Partner of Section 32, a venture fund that invests in companies and inventors that are changing the way humans use technology and the way technology betters humanity. Previously, he served as the chairman of Foundation Medicine (NASDAQ:FMI) and before that as the CEO (May 2011-February 2017). He currently serves as a member of the Board of Directors for Tango Therapeutics, Singular Genomics, Adaptive Biotechnologies, the Personalized Medicine Coalition, Thrive, and the Mission Hospital Foundation, in addition to his Board Chair position with Foundation Medicine. As a physician with more than 20 years of executive experience with companies at the forefront of clinical diagnostics and genomics, Dr. Pellini brings a breadth of understanding in personalized medicine, with a particular interest and focus on defeating cancer. Dr. Pellini is a member of the President’s Leadership Council at Thomas Jefferson University and Jefferson Health, as well as the Advisory Board for Mission Hospital’s Cancer Institute (Provident/St. Joseph Health). Dr. Pellini received a BA from Boston College, an MBA from Drexel University and an MD from Jefferson Medical College.
Biography
Dr. Adrian Lee has had a key role in shaping precision medicine research at the University of Pittsburgh and personalized care in the large UPMC integrated finance and delivery healthcare system. An example of the early progress in precision medicine is research and implementation of pharmacogenomics, and development of computational systems and architecture for sharing of clinical and genomic data. The goal of Dr. Lee’s laboratory is to translate basic cell and molecular research findings into the understanding and treatment of breast cancer. He is currently leading an effort to sequence metastatic breast cancers to identify vulnerabilities for novel precision therapies. Dr Lee has published over 160 peer reviewed research articles. In 2018 Dr. Lee was awarded the Terri L Chapman award from Susan G. Komen for the Cure, the PNC Elsie Hillman Distinguished Scholar award, and the University of Pittsburgh Biomedical Graduate Scholar Association (BGSA) Distinguished Mentor Award.
Biography
Currently Dr. Diperna leads the Oncology Service Line for the Dignity Health Cancer Institute of Greater Sacramento Region. His interest is in developing and implementing new healthcare technologies, specifically surgical devices and diagnostics, as well as digital healthcare initiatives and systematic precision medicine and molecular profiling algorithms. He graduated with honors from Mount Sinai School Of Medicine Of City University Of New York in 1998. Having more than 21 years of diverse experiences, especially in thoracic surgery, general surgery, Dr. Costanzo Diperna affiliates with many hospitals including Mercy San Juan Medical Center, Sierra Nevada Memorial Hospital, cooperates with many other doctors and specialists in medical group Dignity Health Medical Foundation.
Biography
Terry Wooten joined Mission Hospital in November 2016 as the Vice President of Operations – Support Services. Wooten is responsible for overall planning, development, coordination, implementation, and management of all administrative functions, services, and related business development activities in order to drive market responsive support services. He will be focused on ensuring high levels of customer service, strong physician partnerships and an engaged workforce in the delivery of care and services. Wooten previously served as Vice President of Clinical Supply Chain at St. Joseph Health where he oversaw the Clinical Supply Chain and the Department of Clinical Effectiveness. He was responsible for working with physicians, clinical leaders and the executive teams at St. Joseph Health’s 14 ministries to develop and implement supply chain strategies that focused on clinical effectiveness and patient outcomes. Prior to this role, Terry served for 10 years as the Business Director of Surgical Services & Endoscopy at St. Joseph Hospital in Orange, California. Wooten received his Master of Health Administration from the University of Southern California, and has been a presenter at many health care conferences covering a variety of topics. He resides in Laguna Niguel and is involved in various charitable activities in the local community.